We are migrating the content of this website during the first semester of 2014 into the new EUR-Lex web-portal. We apologise if some content is out of date before the migration. We will publish all updates and corrections in the new version of the portal.
Do you have any questions? Contact us.
The European Union (EU) has adopted measures to prevent and control bluetongue – the range and scope of the measures depend on whether the presence of the disease on holdings is confirmed or merely suspected.
This Directive lays down measures to control and eradicate bluetongue.
Suspected or confirmed cases of the bluetongue virus must be notified to the competent authority of the Member State concerned before implementing the required measures.
Measures for suspected cases of the disease
Where the presence of the disease is suspected in a flock, the official veterinarian is to place the holding(s) concerned under surveillance and undertake a certain number of investigative measures (surveillance of the holding, inventory of the animals and the premises, epidemiological survey, etc.) and protective measures (ban on movements of animals, treatment of animals with insecticide, destruction and disposal of animal carcases, etc.).
Measures for confirmed cases of the disease
If the presence of the disease is confirmed, the official veterinarian will extend the measures introduced on suspicion to all holdings within a 20-km radius around the infected holding(s). He will also carry out an epidemiological survey and may launch a vaccination programme around the outbreaks of bluetongue.
Where the presence of the disease is confirmed, the competent authority must establish a protection zone and a surveillance zone around the holdings.
Protection zone and surveillance zone
The protection zone will extend over a radius of at least 100 kilometres around the infected holding(s). Within that zone, all holdings with animals must be identified and the animals may not leave the zone. The competent authority must establish an epidemiological surveillance programme. A vaccination programme may also be set up within the protection zone.
The surveillance zone will extend for at least 50 kilometres beyond the protection zone. Within that zone, the measures for identification, restriction of movement and epidemiological surveillance applicable within the protection zone must be implemented. However, the vaccination of animals against bluetongue is forbidden.
The protection and surveillance zones may be extended or reduced depending on the epidemiological, geographical, ecological or meteorological circumstances.
Derogations and supplementary measures
The Commission, assisted by the Standing Committee on the Food Chain and Animal Health may adopt supplementary or derogatory measures. In particular provisions may be adopted to allow animals to leave the protection and surveillance zones under certain conditions.
Each Member State designates a national laboratory responsible for carrying out the laboratory tests provided for by this Directive and then informs the other Member States and the public of the laboratory’s contact details. Each national laboratory must cooperate with the Community reference laboratory located at Pirbright (United Kingdom).
The outbreak of bluetongue at the end of the 1990s demonstrated that the Community legislation then in force did not deal with the specific features of the disease. This Directive takes over a number of measures laid down by Directive 92/35/EEC concerning African horse sickness, which were adaptable to cover bluetongue.
|Act||Entry into force||Deadline for transposition in the Member States||Official Journal|
OJ L 327 of 22.12.2000
|Amending act(s)||Entry into force||Deadline for transposition in the Member States||Official Journal|
OJ L 219 of 14.8.2008
The successive amendments and corrections to Directive 2000/75/EC have been incorporated in the original text. This consolidated version is of documentary value only.